Skip to main content
Access Resources

MJFF Publications

6361 - 6370 of 7540 Results
Title
Year
  • Year
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • RESTRICTED
    Title: The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2014.12.009
    Citation Count: 152
  • RESTRICTED
    Title: Targeting β-arrestin2 in the treatment of l -DOPA–induced dyskinesia in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1502740112
    Citation Count: 89
  • RESTRICTED
    Title: Impact of Parkinson's disease risk loci on age at onset
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26237
    Best OA location URL:
    Citation Count: 38
  • RESTRICTED
    Title: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.202
    Citation Count: 19
  • RESTRICTED
    Title: Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/npjparkd.2015.2
    Citation Count: 104
  • RESTRICTED
    Title: LRRK2 mutations and neurotoxicant susceptibility
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1535370215579162
    Citation Count: 27
  • RESTRICTED
    Title: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064
    Citation Count: 43
  • RESTRICTED
    Title: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the Brain
    Journal Name: ACS Synthetic Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040
    Citation Count: 26
  • RESTRICTED
    Title: Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3997
    Citation Count: 508
  • RESTRICTED
    Title: Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and Mutagenesis
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/ja5131726
    Best OA location URL:
    Citation Count: 129
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.